This retrospective cohort study compared the effect of amantadine on levodopa-induced dyskinesia (LID) onset with use of anticholinergics and monoamine oxidase type B inhibitors in patients with Parkinson’s disease. The authors concluded that early treatment with amantadine may delay LID onset more than treatment with other symptomatic agents.
ABSTRACT & COMMENTARY
Does Amantadine Treatment Reduce Levodopa-Induced Dyskinesias?
May 1, 2022